Al's Last Trip | Seven Days Vermont

Please support our work!

Donate  Advertise

Al's Last Trip 

Published May 1, 2008 at 10:50 a.m.

Could we ever know — is it even worth contemplating — what impact the Swiss chemist Albert Hofmann, who died yesterday at 102, had on human affairs?

On April 16, 1943, in his lab at Sandoz Corp. in Basel, Hoffman absorbed a small amount of LSD-25, a substance he had isolated in 1938 while researching the potential pharmaceutical properties of the ergot fungus. A few days later, he ingested 250 mg of LSD-25. He went home and lay down and, as he described the experience, "sank into a not unpleasant intoxicated-like condition, characterized by an extremely stimulated imagination."

In a dreamlike state, with eyes closed (I found the daylight to be unpleasantly glaring), I perceived an uninterrupted stream of fantastic pictures, extraordinary shapes with intense, kaleidoscopic play of colors. After some two hours this condition faded away. This was, altogether, a remarkable experience . . . .

No kidding.

In 1954, Oscar Janiger, an LA psychiatrist, began a series of controlled studies, eventually dosing more than 950 people, from all walks of life, age 18 to 81. Janiger's aim was simply to see how different people reacted to LSD. What he found was that the substance had a profound effect on creativity and spirituality.

Janiger's research was shut down in 1962 by the U.S. government, which eventually led Sandoz to cease production of LSD.  The drug, which was a legal experimental psychiatric treatment until 1966, has been manufactured illegally ever since, although the CIA didn't have any trouble getting its hands on it.

LSD never really went away, and in fact was pretty popular again in the 1990s. That resurgence came to an end with the arrest of two chemists, William Pickard and Clyde Apperson. The Drug Enforcement Agency estimated that the availability of LSD dropped by 95 percent. Pickard was sentenced In November 2003 to life without parole, and Apperson got 30 years with no possibility of early release.

Hoffman was scheduled to speak at the World Psychedelic Forum, in Basel, in March, but poor health kept him away.

Blogged with the Flock Browser

One or more images has been removed from this article. For further information, contact [email protected].
Got something to say? Send a letter to the editor and we'll publish your feedback in print!

Tags: ,

More By This Author

About The Author

Brian Wallstin


Comments are closed.

From 2014-2020, Seven Days allowed readers to comment on all stories posted on our website. While we've appreciated the suggestions and insights, right now Seven Days is prioritizing our core mission — producing high-quality, responsible local journalism — over moderating online debates between readers.

To criticize, correct or praise our reporting, please send us a letter to the editor or send us a tip. We’ll check it out and report the results.

Online comments may return when we have better tech tools for managing them. Thanks for reading.

Keep up with us Seven Days a week!

Sign up for our fun and informative

All content © 2024 Da Capo Publishing, Inc. 255 So. Champlain St. Ste. 5, Burlington, VT 05401

Advertising Policy  |  Privacy Policy  |  Contact Us  |  About Us  |  Help
Website powered by Foundation